• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植后六年期间的血清促红细胞生成素与红细胞生成

Serum erythropoietin and erythropoiesis during six years after kidney transplantation.

作者信息

Goch J, Birgegård G, Wikström B, Backman U, Wadström J, Danielson B G

机构信息

Department of Internal Medicine, University Hospital, Uppsala, Sweden.

出版信息

Nephron. 1996;74(4):687-93. doi: 10.1159/000189475.

DOI:10.1159/000189475
PMID:8956302
Abstract

We have studied serum erythropoietin (EPO) levels during 6 years after kidney transplantation in 16 patients. There was a serum EPO peak around 50 mU/ml after 5 weeks. After 3 months the serum EPO level stabilized at around 30 mU/ml. Patients with good transplant function had significantly higher serum EPO levels and normalized their hemoglobin (Hb) after a mean of 3 months. If transplant function was good, Hb was normalized even if the serum EPO was only slightly elevated. Patients with poor transplant function had lower serum EPO and Hb levels. We concluded that a good transplant function is the key to a normal erythropoiesis and that small amounts of EPO are needed to improve Hb.

摘要

我们研究了16例肾移植患者肾移植后6年期间的血清促红细胞生成素(EPO)水平。5周后血清EPO峰值约为50 mU/ml。3个月后血清EPO水平稳定在30 mU/ml左右。移植功能良好的患者血清EPO水平显著更高,平均3个月后血红蛋白(Hb)恢复正常。如果移植功能良好,即使血清EPO仅略有升高,Hb也会恢复正常。移植功能差的患者血清EPO和Hb水平较低。我们得出结论,良好的移植功能是正常红细胞生成的关键,改善Hb需要少量EPO。

相似文献

1
Serum erythropoietin and erythropoiesis during six years after kidney transplantation.肾移植后六年期间的血清促红细胞生成素与红细胞生成
Nephron. 1996;74(4):687-93. doi: 10.1159/000189475.
2
[Erythropoietin and erythropoiesis after kidney transplantation].[肾移植后的促红细胞生成素与红细胞生成]
Vnitr Lek. 1996 Aug;42(8):540-4.
3
Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.肾移植后的红细胞生成:促红细胞生成素、爆式促进活性及早期红系祖细胞的作用
Eur J Med Res. 2001 Jan 29;6(1):27-32.
4
Erythropoiesis and renal transplant pregnancy.
Clin Transplant. 2000 Apr;14(2):127-35. doi: 10.1034/j.1399-0012.2000.140205.x.
5
Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis.氯沙坦或依那普利对有或无移植后红细胞增多症患者血红蛋白、循环促红细胞生成素及胰岛素样生长因子-1的影响。
Am J Kidney Dis. 2002 Mar;39(3):600-8. doi: 10.1053/ajkd.2002.31404.
6
Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.血液透析患者和肾移植受者的血清促红细胞生成素水平及其与红细胞生成系统的相关性。
Transplant Proc. 2007 May;39(4):1051-3. doi: 10.1016/j.transproceed.2007.03.048.
7
Re-establishment of erythropoietin responsiveness in end-stage renal failure following renal transplantation.肾移植后终末期肾衰竭患者促红细胞生成素反应性的重建。
Clin Nephrol. 1995 Oct;44(4):241-7.
8
[Erythropoiesis and serum erythropoietin concentrations before and after kidney allotransplantation].[同种异体肾移植前后的红细胞生成及血清促红细胞生成素浓度]
Nephron. 1989;51 Suppl 1:29-33. doi: 10.1159/000185568.
9
Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function.促红细胞生成素缺乏和相对抵抗会导致肾功能正常的肾移植受者出现贫血。
Nephrol Dial Transplant. 1996 Jan;11(1):177-81.
10
Interrelationship between erythropoietin and erythropoiesis: insights from renal transplantation.促红细胞生成素与红细胞生成之间的相互关系:肾移植的见解
Am J Kidney Dis. 1991 Oct;18(4 Suppl 1):54-6.

引用本文的文献

1
Fount, fate, features, and function of renal erythropoietin-producing cells.肾促红细胞生成素产生细胞的起源、命运、特征和功能。
Pflugers Arch. 2022 Aug;474(8):783-797. doi: 10.1007/s00424-022-02714-7. Epub 2022 Jun 24.
2
Heritability and association with distinct genetic loci of erythropoietin levels in the general population.普通人群中促红细胞生成素水平的遗传力及其与不同基因位点的关联。
Haematologica. 2021 Sep 1;106(9):2499-2501. doi: 10.3324/haematol.2021.278389.
3
The pharmacokinetic profile of recombinant human erythropoietin is unchanged in patients undergoing cardiac surgery.
接受心脏手术的患者中,重组人促红细胞生成素的药代动力学特征未发生改变。
Eur J Clin Pharmacol. 2009 Mar;65(3):273-9. doi: 10.1007/s00228-008-0575-6. Epub 2008 Oct 30.